Page last updated: 2024-08-21

dronabinol and Dementia

dronabinol has been researched along with Dementia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's6 (54.55)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Bagetta, G; Boccella, S; Corasaniti, MT; Guida, F; Luongo, L; Maione, S; Nicotera, P; Scuteri, D; Tonin, P1
Hernandez, C; Laiteerapong, N; Sawicki, SM; Zahradnik, EK1
Ellison, JM; Forester, BP; Harper, DG; Stolyar, A; Woodward, MR1
Ahmed, AI; Burger, DM; Colbers, A; Kramers, C; Olde Rikkert, MG; van den Elsen, GA; van der Marck, MA1
Ahmed, AI; Feuth, T; Kramers, C; Olde Rikkert, MG; Rosenberg, PB; van den Elsen, GA; van der Marck, MA; Verkes, RJ1
Ahmed, AIA; Feuth, T; Olde Rikkert, MGM; van den Elsen, GAH; van der Marck, MA; Verkes, RJ1
Ahmed, AI; Kramers, C; Marijnissen, RM; Olde Rikkert, MG; Tobben, L; van den Elsen, GA; van der Marck, MA; Verkes, RJ1
Cairns, R; Howard, R; Krishnan, S1
Homan, P; Schüpbach, B; Seifritz, E; Strik, W; Walther, S1
Eichmann, U; Kunz, D; Mahlberg, R; Walther, S1
Mahlberg, R; Walther, S1

Reviews

1 review(s) available for dronabinol and Dementia

ArticleYear
Cannabinoids for the treatment of dementia.
    The Cochrane database of systematic reviews, 2009, Apr-15, Issue:2

    Topics: Alzheimer Disease; Cannabinoids; Dementia; Dronabinol; Humans; Psychotropic Drugs

2009

Trials

8 trial(s) available for dronabinol and Dementia

ArticleYear
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 153

    Topics: Aged; Cannabidiol; Chronic Pain; Dementia; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Oral Sprays; Psychomotor Agitation; Randomized Controlled Trials as Topic

2022
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia.
    Psychopharmacology, 2015, Volume: 232, Issue:14

    Topics: Aged; Aged, 80 and over; Blood Pressure; Cross-Over Studies; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Frail Elderly; Hallucinogens; Heart Rate; Humans; Male

2015
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.
    Neurology, 2015, Jun-09, Volume: 84, Issue:23

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Aggression; Cannabinoid Receptor Agonists; Dementia; Double-Blind Method; Dronabinol; Humans; Male; Psychomotor Agitation; Quality of Life; Treatment Outcome

2015
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2015, Volume: 23, Issue:12

    Topics: Aged; Cross-Over Studies; Dementia; Double-Blind Method; Dronabinol; Female; Humans; Male; Mental Disorders; Netherlands; Psychotropic Drugs; Treatment Outcome

2015
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial.
    Journal of psychopharmacology (Oxford, England), 2017, Volume: 31, Issue:2

    Topics: Aged; Cross-Over Studies; Dementia; Double-Blind Method; Dronabinol; Female; Gait; Humans; Male; Postural Balance; Posture

2017
Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:2

    Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Cross-Over Studies; Dementia; Dronabinol; Humans; Male; Psychomotor Agitation

2011
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.
    Psychopharmacology, 2006, Volume: 185, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Dronabinol; Electroencephalography; Female; Hallucinogens; Humans; Male; Motor Activity; Pilot Projects; Psychomotor Agitation; Sleep Wake Disorders

2006
Actigraphy in agitated patients with dementia. Monitoring treatment outcomes.
    Zeitschrift fur Gerontologie und Geriatrie, 2007, Volume: 40, Issue:3

    Topics: Aged; Aged, 80 and over; Dementia; Dronabinol; Female; Humans; Male; Melatonin; Middle Aged; Monitoring, Ambulatory; Motor Activity; Outcome Assessment, Health Care; Psychomotor Agitation; Psychotropic Drugs; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

2007

Other Studies

2 other study(ies) available for dronabinol and Dementia

ArticleYear
The Use of Dispensary-Obtained Tetrahydrocannabinol as a Treatment for Neuropsychiatric Symptoms of Dementia.
    The Journal of clinical psychiatry, 2023, 09-18, Volume: 84, Issue:6

    Topics: Aged; Antipsychotic Agents; Anxiety; Anxiety Disorders; Dementia; Dronabinol; Humans

2023
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:4

    Topics: Aggression; Anorexia; Antidepressive Agents; Antipsychotic Agents; Cannabinoid Receptor Agonists; Cholinesterase Inhibitors; Cohort Studies; Dementia; Dronabinol; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Mental Disorders; Psychomotor Agitation; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2014